Jun (Atsushi) Nakamura

Registered Patent Agent

1-703-205-8000
Jun Nakamara

Mr. Jun (Atsushi) Nakamura has over 30 years of experience in the corporate IP management field in Japan. His experience began in preparing patent specifications for Japanese prosecution and shifted to foreign, prosecutions. His responsibility was also in licensing negotiations, litigation as well as opinion work, which provide in-house analytic conclusion on the validity and/or infringement issues of patents. He has also an extensive experience in Corporate Patent Portfolio management.

Services

Industries

Speaking Engagements

    Current Speaking Engagements

    Previous Speaking Engagements

  • Patent Law Institute 2020: Critical Issues & Best Practices

    PLI 2020: Live Webcast

    April 02 2020

  • New Trademark Developments and Rules in the U.S.P.T.O

    Trademark Day Sweden

    January 23 2020

  • Inter-Collegiate Licensing Association Winter Symposium

    ICLA Winter Symposium

    January 15 2020

  • Claim Drafting and Amendment Workshop Under EP and US Practices

    2019 JPAA Workshop

    November 01 2019

Articles

  • July 24, 2020

    Washington, D.C. NFL Team Loses Race to the Trademark Office: Does it Matter?

    by Michael. T Smith | IPWatchDog

    In surveys throughout the Washington, D.C. metro area, three possible replacement names have emerged as favorites among the fans: Warriors, Red Wolves, and Redtails. Armed with the knowledge of the name change and the relative popularity of the possible replacement names, two enterprising individuals have applied to obtain a federal trademark registration for the marks WARRIORS, WASHINGTON RED WOLVES, and WASHINGTON REDTAILS, respectively. Neither applicant appears to be connected to the owners of the Washington D.C. professional football team.

    Learn More
  • July 10, 2020

    Could good intentions lead to future danger?

    by MaryAnne Armstrong, Ph.D. | LSIPR

    MaryAnne Armstrong, Ph.D. discusses the potential risks to IP rights with open-access to technology, medicines and devices in the fight against COVID-19 in the latest issue of LSIPR.

    Learn More

Presentations